GlycoMimetics Inc (GLYC):企業の財務・戦略的SWOT分析

◆英語タイトル:GlycoMimetics Inc (GLYC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH141235FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

GlycoMimetics Inc (GLYC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that discovers, develops and commercializes small molecule drugs. The company’s pipeline products comprise uproleselan, rivipansel (GMI-1070), under phase III clinical trial is an anti-inflammatory compound to treat vaso-occlusive crisis of sickle cell disease and blood cancers. It is also designing galectin inhibitors for advancing treatment options of various diseases. GlycoMimetics designs and tests viral and bacterial entry inhibitors dendritic cell receptor. The company uses proprietary glycobiology technology to develop treatments for diseases. It also offers clinical research programs. GlycoMimetics is headquartered in Rockville, Maryland, the US.

GlycoMimetics Inc Key Recent Developments

Mar 02,2021: GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2020
Feb 23,2021: GlycoMimetics to Report Fourth Quarter and Year-End 2020 Financial Results on March 2
Nov 06,2020: GlycoMimetics reports highlights and financial results for third quarter 2020
Jul 31,2020: GlycoMimetics reports highlights and financial results for second quarter 2020
May 01,2020: GlycoMimetics reports operational highlights and financial results for first quarter 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
GlycoMimetics Inc – Key Facts
GlycoMimetics Inc – Key Employees
GlycoMimetics Inc – Key Employee Biographies
GlycoMimetics Inc – Major Products and Services
GlycoMimetics Inc – History
GlycoMimetics Inc – Company Statement
GlycoMimetics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
GlycoMimetics Inc – Business Description
R&D Overview
GlycoMimetics Inc – Corporate Strategy
GlycoMimetics Inc – SWOT Analysis
SWOT Analysis – Overview
GlycoMimetics Inc – Strengths
GlycoMimetics Inc – Weaknesses
GlycoMimetics Inc – Opportunities
GlycoMimetics Inc – Threats
GlycoMimetics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
GlycoMimetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GlycoMimetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GlycoMimetics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 02, 2021: GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2020
Feb 23, 2021: GlycoMimetics to Report Fourth Quarter and Year-End 2020 Financial Results on March 2
Nov 06, 2020: GlycoMimetics reports highlights and financial results for third quarter 2020
Jul 31, 2020: GlycoMimetics reports highlights and financial results for second quarter 2020
May 01, 2020: GlycoMimetics reports operational highlights and financial results for first quarter 2020
Feb 28, 2020: GlycoMimetics reports highlights and financial results for fourth quarter and year-end 2019
Jan 07, 2020: Apollomics buys AML programme rights in Greater China
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
GlycoMimetics Inc, Key Facts
GlycoMimetics Inc, Key Employees
GlycoMimetics Inc, Key Employee Biographies
GlycoMimetics Inc, Major Products and Services
GlycoMimetics Inc, History
GlycoMimetics Inc, Key Competitors
GlycoMimetics Inc, Ratios based on current share price
GlycoMimetics Inc, Annual Ratios
GlycoMimetics Inc, Annual Ratios (Cont...1)
GlycoMimetics Inc, Interim Ratios
GlycoMimetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GlycoMimetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GlycoMimetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[GlycoMimetics Inc (GLYC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ITT Inc.:企業の戦略・SWOT・財務分析
    ITT Inc. - Strategy, SWOT and Corporate Finance Report Summary ITT Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Hokkaido Gas Co Ltd (9534):企業の財務・戦略的SWOT分析
    Summary Hokkaido Gas Co Ltd (Hokkaido Gas), a subsidiary of Kita Gas Group is an oil and gas company that distributes petroleum products. The company’s business activities include gas business, heat supply, power supply, purification and sale of gas by-products, and production and sale of gas applia …
  • Globus Medical, Inc. (GMED)-医療機器分野:企業M&A・提携分析
    Summary Globus Medical, Inc. (Globus) is a medical device company which manufactures and markets musculoskeletal implants with focus on the treatment of spine disorders. The company’s product portfolio includes biomaterial products, cervical, deformity, intervertebral fusion, minimally invasive, mot …
  • Delta Apparel, Inc. (DLA):企業の財務・戦略的SWOT分析
    Delta Apparel, Inc. (DLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Flowserve Corporation:企業の戦略・SWOT・財務情報
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Petro Welt Technologies AG (O2C):企業の財務・戦略的SWOT分析
    Petro Welt Technologies AG (O2C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sirona Biochem Corp (SBM):企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agent …
  • OpGen Inc (OPGN)-医療機器分野:企業M&A・提携分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • California Institute for Biomedical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary California Institute for Biomedical Research (Calibr) is a not for profit organization that offers translational research. The organization discovers and develops therapies for unmet medical needs. It conducts research in the human disease areas of degenerative and age-related diseases, canc …
  • Denali Therapeutics Inc:企業のM&A・事業提携・投資動向
    Denali Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Denali Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Aevis Victoria SA (AEVS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aevis Victoria SA (Aevis Victoria), a subsidiary of Medical Research, Services & Investments SA, is a diversified company that invests in healthcare, hospitality, telemedicine, life sciences and lifestyle. It owns and operates outpatient surgical centres, hospitals, medical network, and cent …
  • Enbridge Energy Partners LP (EEP)-石油・ガス分野:企業M&A・提携分析
    Summary Enbridge Energy Partners, L.P. (EEP) is an independent midstream energy company. The company owns and operates crude oil and liquid petroleum transportation and storage assets, and natural gas gathering, treating, processing, transportation and marketing assets in the US. Its portfolio of as …
  • The McClatchy Company:企業の戦略・SWOT・財務分析
    The McClatchy Company - Strategy, SWOT and Corporate Finance Report Summary The McClatchy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Royal Caribbean Cruises Ltd.:戦略・SWOT・企業財務分析
    Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report Summary Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • General Cable Corporation:企業の戦略・SWOT・財務情報
    General Cable Corporation - Strategy, SWOT and Corporate Finance Report Summary General Cable Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • DEPObank – Banca Depositaria Italiana SpA:企業の戦略的SWOT分析
    DEPObank - Banca Depositaria Italiana SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • PGNiG SA (PGN):企業の財務・戦略的SWOT分析
    PGNiG SA (PGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Ctrip.Com International Ltd
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Dako AS-医療機器分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • PT. Millennium Pharmacon International TBK (SDPC):企業の財務・戦略的SWOT分析
    PT. Millennium Pharmacon International TBK (SDPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆